1. Explain the advantage of operation research methods such as simulation over clinical trial methods in determining the best control measure for Hepatitis B.
2. In what ways do the decision and Markov models provide cost-effective ways of combating the disease?
3. Discuss how multidisciplinary background is an asset in finding a solution for the problem described in the case.
4. Besides health care, in what other domain could such a modeling approach help reduce cost?